REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 126 filers reported holding REVOLUTION MEDICINES INC in Q1 2022. The put-call ratio across all filers is 0.16 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $585 | +8.5% | 21,137 | +4.8% | 0.00% | 0.0% |
| Q2 2023 | $539 | +11.6% | 20,164 | -9.5% | 0.00% | +33.3% |
| Q1 2023 | $483 | +9.5% | 22,285 | +20.2% | 0.00% | 0.0% |
| Q4 2022 | $441 | -99.9% | 18,534 | -5.8% | 0.00% | 0.0% |
| Q3 2022 | $388,000 | +55.8% | 19,678 | +101.8% | 0.00% | +200.0% |
| Q1 2022 | $249,000 | +5.5% | 9,752 | +3.8% | 0.00% | 0.0% |
| Q4 2021 | $236,000 | +13.5% | 9,392 | +24.3% | 0.00% | 0.0% |
| Q3 2021 | $208,000 | – | 7,557 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,524,031 | $151,966,000 | 28.85% |
| Ponoi II Management, LLC | 685,011 | $18,845,000 | 27.92% |
| Ponoi Management, LLC | 685,011 | $18,845,000 | 16.73% |
| Column Group LLC | 3,347,245 | $92,083,000 | 10.48% |
| TRV GP IV, LLC | 1,419,900 | $39,061,000 | 8.86% |
| Cormorant Asset Management, LP | 3,144,700 | $86,511,000 | 3.52% |
| Boxer Capital, LLC | 3,484,264 | $95,852,000 | 3.35% |
| BVF INC/IL | 2,485,049 | $68,364,000 | 2.67% |
| Casdin Capital, LLC | 2,800,000 | $77,028,000 | 1.92% |
| COMMODORE CAPITAL LP | 226,228 | $6,224,000 | 1.64% |